(Q51560688)

English

Supplementation of N-acetylcysteine inhibits NFkappaB activation and protects against alloxan-induced diabetes in CD-1 mice.

scientific article published in October 1999

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10506589

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/10506589

title

Supplementation of N-acetylcysteine inhibits NFkappaB activation and protects against alloxan-induced diabetes in CD-1 mice. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10506589

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/10506589

1 reference

Ho E

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10506589

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/10506589

Chen G

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10506589

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/10506589

Bray TM

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10506589

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/10506589

language of work or name

English

0 references

publication date

1 October 1999

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10506589

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/10506589

published in

FASEB Journal

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10506589

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/10506589

volume

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10506589

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/10506589

issue

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10506589

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/10506589

page(s)

1845-1854

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10506589

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/10506589

Identifiers

DOI

10.1096/FASEBJ.13.13.1845

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10506589

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/10506589

PubMed publication ID

10506589

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10506589

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/10506589

(Q51560688)

Supplementation of N-acetylcysteine inhibits NFkappaB activation and protects against alloxan-induced diabetes in CD-1 mice.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)